The human gene for plasminogen activator inhibitor type-1 (PAI-1) has been isolated and its promoter region characterized. PAI-1 regulation by glucocortiooids, transforming growth factar-fJ (TGF-p) and the phorbol ester PMA is shown to be exerted at the promoter level. A fragment spanning 805 nudeotides of the 5 1 flanking and 72 of the 5' untraslated region contain information enough to promote transcription and to respond to glucocorticoids when fused to a reporter gene and transfected into human fibrosarcoma cells. A moderately repetitive ENA sequence, containing a TATA box, a CSE consensus, a Z-ENA forming sequence and two imperfect direct repeats at the extremities, is present a few nucleotides 5 1 of the human PAI-1 gene transcription start site, raising the possibility that this gene could have been activated by ENA insertion during evolution.
the SERPTN (serins protease inhibitor) family, and their structures have been recently elucidated by cENA cloning (8) (9) (10) (11) (12) (13) (14) . PAI-1 is an arg-serpin, having an arginine residue at the reactive center (11) . The human PAI-1 gene has been localized an the long arm of chromosome 7 (10, 15) and its irrtron-exan distribution recently determined (16) .
PAI-1 production is influenced by a number of hormones and growth factors (7, (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . We have recently reported that transforming growth factor-6 (TGF-B) and glucooarticoids cause an enhancement of PAI-1 activity and synthesis in human WI-38 lung fibroblasts and HT-1080 fibrosarcoma cells, and increase cellular PAI-1 niPNA levels (29, 30) . To further study these mechanisms, we have now cloned the human PAI-1 gene, identified its promoter region, and found that TGF-{5, glucocorticoids and the phorbol ester phorbol nyristate acetate (MA) enhance PAI-1 transcription rate acting at a unique transcription initiation site. We also report that a fragment spanning 805 nudeotides of the 5 1 flanking and 72 of the 5' untraslated region of the PAI-1 gene fused to the coding sequence of the E.coli CAT gene has promoter activity and responds to glucocorticoids when transfected into HT-1080 cells. Further analysis of the promoter region has shown the presence of a GKE consensus and a Z-ENA forming unit in a sequence which contains a low level homology to the Alu sequence, and is moderately repeated in the human genome. Therefore, the human PAI-1 gene may have acquired regulatory sequences by insertion during evolution.
Deoxy-and dideoxytriphosphates were purchased from P.L. Biochemicals. i'-compounds were from Amarsham Co. (UK). All restriction enzymes, T4 ENA ligase and SI Nuclease were from Boehringer Mannheim QsbH (West Germany). Porcine transforming growth factor-fl type 1 was from R & D Systems (Minneapolis, MN, USA). Dexamethasone and phorbol 12-im/ristate 13-acetate were from Sigma (St. Iouis, MO, USA). All other reagents were of the highest purity grade. Bacterial strains, plasmids and phacre vectors Escherichia coli K12, strain HB 101, was used for transformation. pTMHLB (31) was used as plasmid vector for subcloning. pEMBIScat (32) , which contains the promoterless CAT gene, carried by the Hindm-BamHI fragment of pSV2cat (33) , was used for the C3\T-canstructians. The human genomic library, a gift of Dr. D. Toniolo, was an BooRI partial digestion of white blood cell DNA cloned in phage EMHL4 (34) .
Genomic library screening and nudeotide sequencing
The screening of the human gencmic library and the Southern blot analysis were perfarmed according to Maniatis et al. (35) . Sequence analysis was carried out either by the chemical degradation method (36) or by a modification of the Sanger dideaxy technique on double-stranded DNA (37) .
Oell cultures
Serum-free cultures of the human fibrosarcama cell line HT-1080 and the embryonal human lung fibroblast cell line WI-38 were incubated for the indicated times, with or without the addition of 5 ng/ml TGF-B or 10" 6 M dexamethasone, as previously described (29, 30) . The human manocyte cell line U937 (38) was cultured in suspension in RHO 1640 with 10% FCS to a density of 5 x 10 5 cells/ml. At that time the phorbol ester IMA in EMSO solution at a final concentration of 100 ng/ml, or the same volume of EMSO, was added to the cells. The cells which were adherent to the culture plate 24 hours after IMA addition (usually 90%) were used for the experiment.
SI nuclease mapping
SI mapping was performed as already described (5) . The probe far the localization of the transcription start site of EAI-1 gene was a doublestranded Hindm-EcoRI fragment, 877 bp long, EcoKI 5'end labeled, obtained from phage lambda PAI-1-9 (see Fig. 1 ). A 600 bp Pok I human B-actin probe, obtained from pHFBA-3'OT (39) was 5'end labeled and used as control (see Preparation of nuclei, PNA elongation and isolation were performed as described by Greenberg and Zif f (43) , except that the nuclei were frozen and stored at -80"C between preparation and analysis, and that the P-labelled KNA was treated with 10 ng/ml ENase (BNase free) (Vforthington B.C., USA) for 7 7
30 minutes at 37"C. 5 x 10 nuclei were used for each assay. About 1 x 10 com were used for hybridization. The hybridization conditions were: 50% formamide, 5 x SSC, 5 x Denhardt's solution, 50 mM phosphate buffer, pH 7.0, 0.1% SDS, 100 ng/ml yeast PNA and 10 \iq/mL pTTIHTfl ENA, 37 # C for three days.
The following ENA probes were used: pAl, a plflfanid carrying the human PAI-1 cENA (11); pAT-PvuH, carrying the human fibronectin cENA (kindly provided by Dr. G. Sebastio); pHFpA-3'UT, coding for the 3 1 untranslated region of human B-actin (39); a plasmid carrying a 540 bp Sacl-iqxil fragment encompassing exon II of mouse B_-microglobulin gene (44); pUC18 vector (45) .
Oljqodeoxvnucleotides synthesis
Oligcdeoxynucleotides, used as hybridization probes or sequencing primers, were synthesized with the Applied Biosystem 381A ENA synthesizer.
The following oligonucleotide probes were used in the study. Probe A (see Fig. 1 ) is a 21mer (5' -TQaJlCTlCllUACAGCGCIC-3') derived from nucleotides 27-47 Of PAI-1 cENA (11) . Probe C is a 28mer (5'-GGGIGCIGGftGIOQOQGAfiGQG?«3ICr
T-3') derived from nucleotides 538-565 of PAI-1 cENA (8) . Probe D is a 39mer already described (11) .
ELTSA
Concentrations of PAI-1 in conditioned culture fluids were measured by an ELISA with a combination of monoclonal and polyclonal antibodies, as previously described (29) ted onto nylon membranes and hybridized to P-labeled human placental ENA.
The hybridization was carried out at 65'C in 750 mM Nad, 75 mM NaCitrate (5 x SSC), 0.5% Ficoll, 0.5% bovine serum albumin, 0.5% polyvinylpyrrolidone, 10 pg of herring sperm ENA per ml, 0.1% sodium dodecyl sulphate (SDS). suggested that the longer EAI-1 cENA clone, pA5 (11) , is coded by about 12 Kbp of genomic EKA, entirely contained in the isolated recombinant lambda clones. The nucleotide sequence of about 1 Kbp at the 5' end ( Fig. 2 ) and of about 2 Kbp at the 3' end (not shown) of the hybridizing genomic region confirmed this result. Icskutoff et al. recently reported that the 3' untranslated region of the EAI-1 gene is not interrupted by introns (16) . Our sequence data confirm this finding, indicating that the EAI-1 mPNA heterogeneity depends on different choice of two polyadenylation sites and not on alternative splicing. tion of the transcription start site
Ihe region of the EAI-1 gene coding for the 5 1 end of the transcription unit was identified in the lambda EAI-1-9 ENA by Southern hybridization using a synthetic 21-raer complementary to nucleotides 27-47 of EAI-1 cENA clone Al (Fig. 1 ENA located 5 1 of the 21-mer hybridization site was determined (Fig. 2) . The transcription initiation point of the EAI-1 mRNA was identified by SI nuclease protection. We hybridized a 5' end-labelled 877 bp Hind m-EcoRl ENA probe, obtained from phage lana-ru EAI-1-9 and containing the first 72 nudeotides of the EAI-1 cENA (see Fig. 3C ), to the total UNA extracted from dexamethasane-treated HT 1080 cells and treated the hybrid with SI nuclease. The sequence of the PAI-1 gene shows a oolinearity with the cCNA sequence from the transcription start site up to a position +144 and then diverges with a consensus sequence far a "donor" splicing site (Fig. 2) . In order to study the molecular mechanism of EAI-l gene regulation, we analyzed by SI mapping the transcription start point during regulation by glucocorticolds, TGF-£ and IMA, using the PAI-1 probe described above. A human p-actin probe, which gives a protected band of 45 nucleotides, was used as a control. The SI analysis ( Fig. 3A and 3B) shows the same major protected PAI-1 band with UNA extracted from control and dexamethasonetreated HT-1080 cells (Fig. 3A, lanes 6-8) , control and TGF-8-treated WI-38 cells (Fig. 3B, lanes 1-4) , control and TGF-p-treated HT-1080 cells (Fig.   3B , lanes 5-6), and control and PMA-treated U937 cells (Fig. 3B, lanes 7 (Fig. 5, lanes 1 and 2) . No protected bands were visible in the lanes corresponding to pEMHLScat-transfected and untransfected cells (lanes 3 and 4 of Fig. 5 ).
We tested whether the responsiveness to glucocorticoids was retained by HT-1080 cells were transiently transfected with pUJJSl-cat (see Materials and Methods) and cultured with and without dexamethasone for 30 hours.
The concentration of EAI-l in the conditioned medium was (jpterminpri by ET.T.SA. The fold increase in EAI-l concentration by dexamethasone treatment was calculated after normalizing the PAI-1 concentration against the protein content of the extract.
For determination of the CAT-activity in cell extracts, a dose-response experiment with increasing amounts of extract was used to assure linearity in the assay. The fold increase of CAT activity by dexamethasone treatment was ralo.i1 nted as the ratio between the slope of the lines relating % acetylation of chloramphenicol and amount of protein in the assay, in nontreated and treated cell extracts, respectively.
Numbers refer to the mean +/~ SD from three independent experiments. Values from each experiment are reported in brackets.
DISCU5SICW
Regulation of most eukaryotic genes is the result of the action of several factors which use different molecular mechanisms. We have studied the regulation of the PAI-1 gene by three factors which are known to act through independent pathways. Steroid hormones affect the transcriptional rate (50, 53) , as well as PNA stability (54) . The regulatory effect can be either direct or indirect, depending on the requirement of protein synthesis The sequenced 807 nucleotides of the EAI-1 promoter were analyzed for the presence of general consensus sequences far regulatory sites. A sequence hanolcgous to the 15 nucleotides proposed by Beato (50) for the GKE and containing the most conserved hexanucleotide TCT(T/C)CT is present once at position -299 frcm the transcription initiation site (Fig. 2) . Tne orientation of the hexanucleotide motif in the EAI-1 5'-flanking sequence is the opposite of that found in the MGV-LTR, but that is compatible with the enhancer properties of GREs (50) . Whether this site corresponds to an authentic GRE remains to be demonstrated. Preliminary results show that a PAI-1-CAT fusion gene carrying 343 nucleotides of 5'-flanking sequence retains the responsiveness to glucocorticoid hormones (not shown). The consensus sequences far nuclear factor I, and for transcrlptian factor AP-1, proposed by Jones et al. (66) and by Angel et al. (60) , respectively, are not present in the 807 bp of the PAI-1 promoter sequenced so far, although several similar sequences could be identified. An Alu-like sequence can be identified between positions -402 and -17. Its structure resenbles that of an unusual Alu sequence, described in the African green moritey genome (47) , in which the first monomer ends with 18 alternating purine-pyrimidines, instead of the A-rich consensus sequence. Imperfect direct repeats flank this element (Fig. 2) , as has been reported far most of the Alu sequences. A sequence alignment reveals a 50% degree of similarity, excluding the poly r«rine-pyrimidine tract, both with the human Alu consensus sequence (48) and with the unusual Alu element described by Saffer (47) . It has been reported that a stretch of dT-dG alternating sequence is highly repeated in the eukaryotic genomes (5 x 10 copies in humans) (67) . No significant hanology is found when the (dT-dG) flanking sequences of the PAI-1 gene are compared with seme of the other genes containing the poly purine-pyrimidine tract (67) . Southern analysis data show that a repetitive sequence is present in the region -806, -192, which do not contain the potential Z-CHA sequence. Dnis, a repetitive Alu-lite sequence, containing a TATA box, a GRE consensus, a Z-ENA forming ispqiipnoe and two imperfect direct repeats at the extremities, is part of the human PAI-1 promoter. Whether or not it contains all of the elements required far correct PAI-1 expression is not yet known. However, the possibility of gene activation, via the insertion of an Alu-like sequence, is extremely attractive. The elucidation of the structure of the PAI-1 promoter region in species different from homo sapiens may provide an answer to this question.
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